Data / Form D filings / Cybele Microbiome, Inc.
Cybele Microbiome, Inc.: Form D filings
Cybele Microbiome, Inc., a biotechnology company in San Diego, CA, filed 4 Form D notices with the SEC between 2022 and 2024. The latest, on March 1, 2024, reports $252,000 sold of a $500,000 offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3210 MERRYFIELD ROW, San Diego, CA, 92121
- Phone
- (734) 355-6316
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1953909
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | New notice | $500,000 | $252,000 | $248,000 | 5 | Feb 20, 2024 | sec.gov |
| Feb 9, 2023 | New notice | $877 | $877 | 19 | Dec 19, 2018 | sec.gov | |
| Nov 16, 2022 | New notice | $1,000,000 | $500,000 | $500,000 | 1 | Nov 4, 2022 | sec.gov |
| Nov 14, 2022 | New notice | $893,500 | $893,500 | 19 | Oct 28, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nicole M. Scott | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 26, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cybele Microbiome, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.